Literature DB >> 30512823

Retinoblastoma

Livia Lumbroso-Le Rouic1.   

Abstract

Retinoblastoma. Retinoblastoma is the most frequent malignant intraocular tumour of childhood. It is a rare disease occurring in very young children. It is a genetic disease due to the mutation of the RB1gene. Today survival is excellent (98%) in developed countries, however lower survival rates are observed in the developing world where children still die of the disease. Visual prognosis depends on the possibility to realize a conservative treatment as well as the size and location of the tumors. The two main presenting signs of retinoblastoma are leukocoria and strabismus. Every suspicion of leukocoria requires prompt fundus examination.

Entities:  

Keywords:  retinoblastoma

Mesh:

Year:  2017        PMID: 30512823

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  4 in total

1.  Knockdown of lncRNA HOTTIP Inhibits Retinoblastoma Progression by Modulating the miR-101-3p/STC1 Axis.

Authors:  XiangWen Yuan; Zhaoyan Sun; Congxian Cui
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

2.  hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis.

Authors:  Guangwei Jiang; Mingxuan Qu; Lili Kong; Xiaoming Song; Shanhao Jiang
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

3.  Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma.

Authors:  Yanjun Wen; Maolin Zhu; Xuerui Zhang; Haodong Xiao; Yan Wei; Peiquan Zhao
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

4.  microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.

Authors:  Chunzhi Li; Jun Zhao; Weiying Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.